These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 18661871

  • 1. Design, development, and optimization of orally disintegrating tablets of etoricoxib using vacuum-drying approach.
    Patel D, Shah M, Shah S, Shah T, Amin A.
    PDA J Pharm Sci Technol; 2008; 62(3):224-32. PubMed ID: 18661871
    [Abstract] [Full Text] [Related]

  • 2. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique.
    Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N.
    AAPS PharmSciTech; 2004 Apr 26; 5(3):e36. PubMed ID: 15760070
    [Abstract] [Full Text] [Related]

  • 3. Optimization of fast dissolving etoricoxib tablets prepared by sublimation technique.
    Patel DM, Patel MM.
    Indian J Pharm Sci; 2008 Jan 26; 70(1):71-6. PubMed ID: 20390084
    [Abstract] [Full Text] [Related]

  • 4. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
    Dehghani H, Taheri A, Homayouni A.
    Curr Drug Deliv; 2017 Jan 26; 14(5):709-717. PubMed ID: 27142108
    [Abstract] [Full Text] [Related]

  • 5. A Comparative Study of Different Proportions of Superdisintegrants: Formulation and Evaluation of Orally Disintegrating Tablets of Salbutamol Sulphate.
    Kumar A, Saharan VA.
    Turk J Pharm Sci; 2017 Apr 26; 14(1):40-48. PubMed ID: 32454593
    [Abstract] [Full Text] [Related]

  • 6. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C, Yilma Z, Abrha S, Yehualaw A.
    PLoS One; 2021 Apr 26; 16(3):e0246648. PubMed ID: 33725014
    [Abstract] [Full Text] [Related]

  • 7. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
    Mostafa HF, Ibrahim MA, Sakr A.
    Pharm Dev Technol; 2013 Apr 26; 18(2):454-63. PubMed ID: 22881389
    [Abstract] [Full Text] [Related]

  • 8. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression.
    Gulsun T, Ozturk N, Kaynak MS, Vural I, Sahin S.
    Pharmazie; 2017 Jul 03; 72(7):389-394. PubMed ID: 29441935
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Systematic screening of compressed ODT excipients: cellulosic versus non-cellulosic.
    Al-Khattawi A, Iyire A, Dennison T, Dahmash E, Bailey CJ, Smith J, Rue P, Mohammed AR.
    Curr Drug Deliv; 2014 Jul 03; 11(4):486-500. PubMed ID: 24655059
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S.
    Int J Pharm; 2012 Feb 28; 423(2):351-9. PubMed ID: 22138608
    [Abstract] [Full Text] [Related]

  • 18. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A, Suliman AS, Shinde S, Naz S, Elkordy AA.
    Int J Pharm; 2016 Mar 30; 501(1-2):87-95. PubMed ID: 26827922
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.